Neurology
Tension-Type Headache
17
Pipeline Programs↗
2
Active Trials↗
9
Companies Involved↗
Tension-type headache is an emerging landscape with 17 programs across 9 companies. The most active players are Tonix Pharmaceuticals, Inc., Pfizer, Vitae Pharmaceuticals Inc., an Allergan affiliate. 8 therapies are approved with 5 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 35
Analysis
Trial Status
12
clinical trials
Completed7 · 58%
Active, not recruiting2 · 17%
Withdrawn1 · 8%
Terminated1 · 8%
Unknown status1 · 8%
Clinical Trials
Trial Activity
12 trials
Efficacy of Euminz® for Tension-Type Headache
Completed·—·Phase 4·NCT01770080·211 enrolled
Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache.
Unknown status·—·Phase 2/3·NCT01012349·152 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)